Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 1 March 2024 Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 868KB) Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 151KB)